PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compound...

FDA Drug Recall #D-1094-2019 — Class II — February 21, 2019

Recall Summary

Recall Number D-1094-2019
Classification Class II — Moderate risk
Date Initiated February 21, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
Location Corvallis, OR
Product Type Drugs
Quantity 9 prescriptions 10, 9ml injection

Product Description

PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

Reason for Recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Distribution Pattern

Dispensed in Oregon

Lot / Code Information

Lot (a)17102018@15,14112018@3, 04122018@21, 14122018@15, 7122018@11, 28122018@69, 20092018@2, (b) 21012019@37, 22012019@31, distributed between 09-01-2018 to 02-20-2019.

Other Recalls from Health Solutions Pharmacy Center Inc ...

Recall # Classification Product Date
D-1110-2019 Class II PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.64MG-5.8MC... Feb 21, 2019
D-1099-2019 Class II PAPAVERINE-PHENTOLAMINE 15-0.5MGMG/ML INJECTABL... Feb 21, 2019
D-1103-2019 Class II PAPAVERINE-PHENTOLAMINE-PGE1 16.6-0.55 MG-11.1 ... Feb 21, 2019
D-1096-2019 Class II PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/... Feb 21, 2019
D-1091-2019 Class II PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (... Feb 21, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.